Odyssey Therapeutics, Inc. (NASDAQ: ODTX) is a Healthcare company (Biotechnology) with a market capitalization of $931M. The Maz Rating grades it against the other companies in its sector.
Odyssey Therapeutics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $19.37, Odyssey Therapeutics, Inc. trades at 2.4x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of 330.5%, return on invested capital of -44.4% and a free cash flow yield of -15.4%. On the balance sheet: a debt-to-equity ratio of 0.06 and a current ratio of 12.94. Over the past 52 weeks the share price ranged from $15.10 to $29.05, with a beta of 1.43.
Odyssey Therapeutics, Inc. does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 2 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.